AIRS Airsculpt Technologies, Inc.
Q3 2025 10-Q
Filed: Nov 7, 2025Period ending Sep 30, 2025
Health Care
Services-Offices & Clinics of Doctors of MedicineSEC EDGAR Airsculpt Technologies, Inc. (AIRS) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 7, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • New operational risk: Closure of UK facility due to financial performance, triggering $2.3M impairment and $1M accelerated rent expense in Q3 2025
- • Updated financial risk: Recorded $4.6M impairment on Salesforce software project, reflecting partial project discontinuation in Q3 2025
Quarterly Financial SummaryXBRL
Revenue
$35M
▼ -17.8% YoY▼ -20.5% QoQ
Net Income
-$10M
▼ -57.5% YoY▼ -1509.5% QoQ
Operating Margin
-27.9%
▼ -1913bp YoY▼ -2965bp QoQ
Net Margin
-27.2%
▼ -1299bp YoY▼ -2584bp QoQ
ROE
-11.6%
Total Assets
$186M
EPS (Diluted)
$-0.16
▼ -45.5% YoY▼ -1500.0% QoQ
Operating Cash Flow
-$225,000
▼ -112.3% YoY▼ -104.5% QoQ
Source: XBRL data from Airsculpt Technologies, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Airsculpt Technologies, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.